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Abstract
Background: After some years of a downward trend, antibiotic prescribing rates in the community have tended to level out
in many countries. There is also wide variation in antibiotic prescribing between general practices, and between countries. There
are still considerable further gains that could be made in reducing inappropriate antibiotic prescribing, but complex interventions
are required. Studies to date have generally evaluated the effect of interventions on antibiotic prescribing in a single consultation
and pragmatic evaluations that assess maintenance of new skills are rare. This paper describes the protocol for a pragmatic,
randomized evaluation of a complex intervention aimed at reducing antibiotic prescribing by primary care clinicians.
Methods and design: We developed a Social Learning Theory based, blended learning program (on-line learning, a practice
based seminar, and context bound learning) called the STAR Educational Program. The 'why of change' is addressed by providing
clinicians in general practice with information on antibiotic resistance in urine samples submitted by their practice and their
antibiotic prescribing data, and facilitating a practice-based seminar on the implications of this data. The 'how of change' is
addressed through context-bound communication skills training and information on antibiotic indication and choice. This
intervention will be evaluated in a trial involving 60 general practices, with general practice as the unit of randomization (clinicians
from each practice to either receive the STAR Educational Program or not) and analysis. The primary outcome will be the
number of antibiotic items dispensed over one year. An economic and process evaluation will also be conducted.
Discussion: This trial will be the first to evaluate the effectiveness of this type of theory-based, blended learning intervention
aimed at reducing antibiotic prescribing by primary care clinicians. Novel aspects include feedback of practice level data on
antimicrobial resistance and prescribing, use of principles from motivational interviewing, training in enhanced communication
skills that incorporates context-bound experience and reflection, and using antibiotic dispensing over one year (as opposed to
antibiotic prescribing in a single consultation) as the main outcome.
Trial registration: Current Controlled Trials ISRCTN63355948.
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Antibiotic resistance is one of the most important public
health issues of our time[1,2]. The reservoir of microbial
sensitivity is a precious international resource that is being
depleted[3]. No completely novel class of antibiotics are
expected on the market for primary care in the medium
term, and the pipeline for new gram negative chemother-
apy is particularly bleak[4]. Therefore, conserving antibi-
otic sensitivity through more appropriate antibiotic use is
a priority[5]. In addition to driving resistance, inappropri-
ate prescribing wastes money, exposes people to unneces-
sary side effects, and encourages future consulting[6,7].
We have shown that antibiotic resistance is common in
primary care and causes symptoms to last for longer in
primary care patients[8] and that patients with resistant
infections incur higher drug and reconsultation costs[9].
Reduced antibiotic prescribing has been shown to be asso-
ciated with reduced levels of resistance both at a national
and local level [10-12].
About 85–90% of all antibiotics are prescribed in primary
care and about 50% of prescription are of questionable
value[13]. In the UK, after some years of a downward
trend in the number of antibiotics dispensed to ambula-
tory patients, rates have levelled out[3]. There is wide var-
iation both within and between countries in antibiotic
prescribing rates that cannot be explained by differences
in the epidemiology of infections[3,14,15]. The UK pre-
scribed nearly twice the amount of antibiotics to ambula-
tory patients as the Netherlands[3]. This suggests that
considerable further gains could safely be made in reduc-
ing inappropriate antibiotic prescribing both at practice
level and nationally.
Whilst previous interventions aimed at general practition-
ers have been successful in reducing antibiotic prescribing
with single consultations as the unit of study[16,17], these
studies have generally achieved small effect sizes, partly
because of low intensity, inflexible interventions that have
often been focused only on generalities about why change
is important[16]. Studies that randomize individual
patients assess prescribing outcomes in single consulta-
tions, and so do not assess maintenance of new skills.
Behaviour in a consultation that is sharply under a
research spotlight may be quite different to prescribing
behaviour over a whole year. This study builds on a con-
siderable amount of development work and integrates
practice antibiotic prescribing and antimicrobial resist-
ance data with innovative developments in the fields of
microbiology, prescribing, education, communication
and behavioural sciences, into a single, yet flexible inter-
vention. The effects will be measured using routinely col-
lected data over a whole year.
We have developed an educational program that inte-
grates a practice-based seminar with on-line learning, fol-
lowed by a maintenance phase. The STAR program aims
to enhance communication within the consultation and
to promote behaviour change by both patients (more
appropriate self-care, fewer antibiotics) and clinicians
(enhanced communication skills, reduced prescribing).
Behaviour change theory is important to both outcomes.
Behaviour change theory
Social Learning Theory makes the critical distinction
between outcome and efficacy expectations, and the evi-
dence in support of verbal persuasion, modelling and
mastery experiences for enhancing self-efficacy[18,19].
Similarly, research on the Theory of Planned Behav-
iour[20,21] makes a conceptual distinction between
beliefs about consequences and beliefs about the ability
to exert control over change. A systematic review of behav-
iour change interventions based on the Theory of Planned
Behaviour found that two thirds of such interventions
were effective[21] and a meta-analysis provides support-
ing evidence[22]. Taken together, these theories and asso-
ciated research provide the foundation for the key
elements of the STAR Program: behaviour change will be
more likely if an intervention addresses both the 'why'
(importance of change; outcome expectations; beliefs
about consequences) and the 'how' (confidence in making
changes; self-efficacy; beliefs about control).
Other evidence
The large body of research on clinician behaviour change
is congruent with this evidence from psychological the-
ory. Put simply, verbal persuasion alone does not usually
alter beliefs about the importance of change or enhance
mastery over efforts to change the consultation itself. Prac-
tice guidelines also have a limited effect on practitioner
behaviour change even when the clinicians have been
involved in their development [23,24]. Over 20 system-
atic reviews [25-27] and reviews of them[28,29] suggest
that behaviour change interventions should be multifac-
eted, assess barriers to change, be responsive to local cir-
cumstances, have a focused and active educational
outreach component, including skills development, and
be resonant with clinicians' values[30,31].
A systematic review identified four randomized control-
led trials comparing a delayed script to an immediate
script for respiratory tract infections and found a relative
risk for lower antibiotic use when a delayed script was
issued of 0.54 for the common cold and 0.25 for otitis
media[32]. A systematic review (completed as part of a
PhD thesis) of interventions aimed at optimizing antibi-
otic prescribing for acute respiratory tract infections in pri-
mary care identified 8 studies evaluating 12
interventions[16]. Studies were of low quality with mod-
est effect sizes (mean of 6% reduction in prescription
rates). Welschen's own subsequent study[33] achieved a
much greater effect size of 12% reduction, with involve-Page 2 of 10
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a number of crucial respects to our proposed study. The
intervention did not identify specific strategies, or demon-
strate communication skills, or provide actual training in
skill acquisition. The face-to-face meetings simply men-
tioned communication, with no subsequent requirement
to practice and reflect on the use of specific strategies.
The STAR Educational Program has been developed in
consultation with clinicians in order to be multi-faceted
(e-learning, outreach, experiential), responsive to local
circumstances (feedback of practice level data on prescrib-
ing and resistance), based on our previous work on every-
day frustrations, challenges and barriers to change
(practice-wide effort; time-efficient consultation strategies
that 'enable' patients and maintain relationships) [34,35]
and skills-based. It is also congruent with the guidance of
Grol and colleagues[36] in its use of a phased engagement
and implementation process to achieve certification and
then to maintain change through web-based exchange of
experiences.
The 'why' of change
The 'why' of clinician behaviour change is addressed not
only by exposure to evidence and opinions, but by
encouraging clinicians to make sense of their prescribing
and microbiological data at a locally meaningful, practice
level. Some clinicians in qualitative studies have suggested
that their prescribing behaviour has no impact on resist-
ance [37-39]. Wales has a novel system that links data on
dispensed antibiotics with antimicrobial sensitivity test
results [40]. The STAR program will feed back this infor-
mation at a practice level as a means of raising discussion
and enhancing motivation to change prescribing[27].
The 'how' of change
Clinicians report that they find it hard not prescribing an
antibiotic while maintaining good relationships with
patients in time-pressured consultations[41]. While
newer work suggests that clinicians find antibiotic pre-
scribing 'less uncomfortable'[42], it is certain that inter-
ventions are more likely to be taken up if they are time
efficient and acceptable to both clinicians and
patients[42]. Clinicians have confirmed that they need
feasible and more effective communication strategies to
successfully change their prescribing[38]. Patients with
common infections consult with a variety of expectations
and may go away with these unfulfilled[43,44] and with
unexpected, unnecessary antibiotics[41,45,46]. Patients'
lack of participation in consultations and 'unvoiced agen-
das' were associated with misunderstandings, unnecessary
and unwanted prescriptions and poor adherence[47].
The STAR program will provide clinicians with training to:
1) ask specific assessment questions in order to 'Lift the
Lid' on patient's unvoiced agendas[48], and 2) use the
'Elicit-Provide-Elicit' strategy to identify and respond to
expectations and information needs appropriately and in
good time[49].
Patient behaviour change is addressed by consultation
strategies that encourage clinicians to avoid a standard
'mini-lecture' about viruses, bacteria and antibiotics, in
favor of eliciting key patient expectations and providing
them with tailored information about the 'why' and 'how'
of self care[34,35].
Innovation in training clinicians
We developed and piloted two novel training methods
that form the backbone of the STAR Program. They draw
on the literature on clinician behaviour change and max-
imize the potential for acquiring and using new skills on
a widespread scale. The 'context-bound learning method'
is a bottom-up, adult learning, experiential approach that
relies on clinicians themselves evaluating the importance
of the issue and then reflecting on authentic case scenar-
ios. Clinicians report that powerful learning flows from
reflecting on their own consultations[34,50]. We have
also developed a self-directed blended e-learning program
that allows learners electronic access to video-rich clinical
challenges before and after face-to-face training. This
method has potentially wide applicability at low cost, and
may assist in maintaining change.
Study intervention
The experimental intervention (the STAR Educational
Program) will take clinicians through a course that will
last approximately five hours. The course uses a wide
range of replicable learning methods (didactic, interac-
tive, reflective learning in groups and as individuals)
focused on two themes: firstly, practice prescribing and
resistance, and secondly, achieving consistency in mes-
sages to patients by learning new ways of handling every-
day consultation challenges. Access to e-learning will be
via the web. Clinicians will be given the choice of whether
or not to share with other study participants their
responses to the attitude questions, as well as their judg-
ments on the different case scenarios contained within the
software. Each clinician will work on an unfolding portfo-
lio of learning that combines their e-learning judgments
with other material. The program consists of seven parts
(see Figure 1):
Part 1 (online)
Clinicians will be presented with four case scenarios and
will be asked to make judgments about how they might
handle these consultations. They will also respond to
questions about their attitudes to resistance and antibiotic
prescribing. They will have access to up-to-date summa-
ries of research evidence, as well as videos giving a rangePage 3 of 10
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aim of this first part of the program is to heighten aware-
ness and encourage the learner to consider their manage-
ment of common infections, their own practice data on
prescribing levels and resistance, practice circumstances
and typical choice of antibiotic class.
Part 2 (online)
Clinicians will record and reflect on four cases involving
infections and their decision whether or not to prescribe
antibiotics. This will be included in their portfolio.
Part 3 (face-to- face)
Practice prescribers will come together for a seminar facil-
itated by a STAR study trainer. This seminar will have
three components: reflections on the on-line learning,
feedback and discussion on prescribing data and on anti-
microbial resistance data from samples submitted by their
practice over a five to ten year period (depending on avail-
ability of data). Clinicians will also be given the opportu-
nity to reflect on the importance they attach to changing
their antibiotic prescribing, as well as the challenges they
face.
Part 4 (online)
Clinicians will be asked to repeat the four case scenarios,
as well as the attitude questions from Part 1, and will be
able to access other participating clinicians' responses. Key
aspects of the principles of good communication in an
antibiotic prescribing consultation will be reinforced. Cli-
The STAR Educational ProgramFigure 1
The STAR Educational Program.Page 4 of 10
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key consulting strategies and they will be encouraged to
examine the consultations for evidence of 'good practice
in an antibiotic consultation'. After they have viewed each
consultation they will be able to view video sequences
where the patient, the clinician and an expert colleague
give their perspectives on the consultation. There will also
be links to supporting evidence.
Part 5 (online)
Clinicians will be asked to describe three of their consul-
tations where they used the new strategies with patients
consulting in usual care conditions. They will reflect on
how they felt, what went well, and on additional novel
ways for solving challenges. These reflections will be
recorded on-line and can be securely shared with other cli-
nicians on the program in a moderated web forum.
Part 6 (online)
An ongoing, active web forum will provide updates on
emerging evidence and allow educators to respond to cli-
nicians' queries, feedback and comments. Clinicians will
be able to start new topics on the forum as well as respond
to topics posted by clinical colleagues.
Part 7 (online)
A booster module will be available 6–8 months after com-
pleting the initial training, which will remind clinicians of
the key strategies and the main messages of the study and
encourage further reflection. This will consist of an online
session reminding clinicians of the STAR consultation
strategies and a video consultation for a common infec-
tion where clinicians are asked to identify key strategies
used during the consultation. Clinicians will also be sent
a snapshot of practice antibiotic prescribing rates from
two recent winter months, compared with the corre-
sponding months for the preceding year, before they were
exposed to the intervention.
Research objectives and outcome measures
Primary Objective
to assess whether exposing prescribers in general practices
to the STAR Program results in fewer antibiotics being dis-
pensed to the practice's patients. This will be assessed by
examining the total number of dispensed oral antibiotics
(with examination of trend by quarter) per 1000 regis-
tered patients, for the year subsequent to the practice
being exposed to the STAR Program, using Prescribing
Audit Reports and Prescribing Catalogues data (PARC).
PARC data have been used widely in research, although
they do not capture private prescriptions for antibiotics
(rare in Wales). The database contains data for dose and
the number/volume of antibiotics, but not the defined
daily dose. Increasing use of delayed prescribing makes
dispensed antibiotics a better outcome measure than pre-
scribed antibiotics, since dispensed antibiotics is a better
proxy for consumed antibiotics.
Secondary Objectives
to investigate other outcomes related to prescribing. The
following secondary outcome measures will be examined:
1. Hospital admission rates for possible complications of
common infections. This will be obtained from routinely
collected data contained in the Patient Episode Database
for Wales (PEDW) which records inpatient/day case care
for all patients in NHS Wales hospitals and for Welsh res-
idents treated elsewhere in the UK.
2. Microbiological sampling rates and proportion of
resistant organisms isolated from urine. These data are
held on the All-Wales Microbiology Database
(DataStore).
3. Summary data will be collected for a sample of practices
through extraction queries run on routinely collected data
from GP computer systems. This will be used to examine:
▪ For patients consulting with selected upper and lower
respiratory tract infections; a) complication rates b) rates
of re-consultations for the same illness episode and for
future similar illness episodes over the following 7 days,
14 days and 31 days c) the difference between prescribed
and dispensed antibiotics.
4. We will compare the primary outcome (PARC dispens-
ing data) for practices in the study, both control and inter-
vention groups, with other Welsh practices outside the
study.
5. A cost effectiveness analysis from an NHS perspective
will be undertaken.
6. A process evaluation of study participants will be car-
ried out in the intervention group.
Method and design
The study is a randomized controlled trial with general
practices as the unit of randomization and analysis.
Sample size
The SD of year-to-year within-practice changes in total dis-
pensed antibiotic rates per 1000 patients between 2001
and 2002 was 70 items per 1000 patients in Wales. To
detect a difference of 10% (73 dispensed antibiotics per
1000 patients) in the change in total antibiotic dispensing
rate per annum between intervention and control prac-
tices, with 90% power, requires 21 practices per group.
However, increasing this to 30 practices per group
(approximately 80–90 clinicians per group) will allow aPage 5 of 10
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prescribing outcomes and b) the effect on resistance in
urine samples: 25 practices per group will give 90% power
to detect a reduction in resistance rates from the current
25% to 20% for Trimethoprim and from the current 6%
to 3% for Cefalexin.
Recruitment
A total of 60 practices will be recruited. Assuming an aver-
age practice size of 5 GPs, we estimate around 160–200
GPs and Nurse Practitioners will take part. The aim is to
recruit all these practices in the first 6 months of the study.
Due to the nature of the intervention, practices must be
adequately computerized and participants will have to
work at least 5 clinical sessions per week to take part in the
STAR Educational Program. We will attempt to recruit at
least two thirds of the prescribers at each practice. This is
due to the nature of the analysis and the feedback pro-
vided on an individual and practice level. Practices who
submit samples to laboratories that are not part of the
DataStore system will be excluded from the study. GPs
and nurse practitioners in Wales will receive an invitation
letter, information sheet, personalized consent form,
return envelope, and a flyer on the study. Additionally,
letters to practice managers will be sent to alert them to
the study.
Randomization
Randomization will take place once all practices have
been recruited in order to obtain an allocation with near
optimal balance for total annual antibiotic prescribing
averaged over the past three years (PARC), practice size
(number of whole time equivalent staff at recruitment)
and proportion of GPs in the practice registered for the
study. Practices will be sub-divided into three blocks and
allocation balanced within each block[51,52]. All possi-
ble allocations within a set will be estimated and the bal-
ance statistic based on the sum of the squares of the
differences between each group on each measure (stand-
ardized). The 1000 possible allocations within each set
with the best balance will be selected and passed to an
independent statistician and one allocation will be
selected at random. Once the final allocation to two
groups has been selected for each set of practices, this
independent statistician will randomly allocate interven-
tion or control to the two groups.
Trial procedures
The STAR Program will be delivered to intervention prac-
tices within the first study year, and then offered to con-
trol practices after the follow-up is complete. Practices will
be followed up one year after the intervention.
Process evaluation
We will conduct a process evaluation in which we:
1. Explore participation in the seminars and use of soft-
ware supported learning and map the clinicians' use of the
system (how often they log in, which pages they use) in
relation to the primary outcome.
2. Complete qualitative interviews with one clinician
from each participating intervention practice to explore
ongoing use of the prescribing and resistance data, the
website, the communication skills, and the acceptability
and perceived usefulness of various components of the
intervention. Clinicians from intervention practices will
be purposively sampled for interview based on gender,
experience, antibiotic prescribing, practice setting and
when they completed the training. Interviews will con-
tinue until all the themes are saturated, previous experi-
ence suggests that this will be around 30
interviews[35,38,53]. The interviews will be conducted
over the telephone and audio recorded. The interviews
will be transcribed for later analysis.
Health economics evaluation
We will also undertake a cost effectiveness analysis from
an NHS perspective. Direct costs/savings will include the
cost of the STAR Program, potentially longer consulta-
tions in intervention practices and potentially fewer anti-
biotics dispensed. Indirect costs/savings will include
differences in antibiotic adverse events, re-consultations
for the same illness and complications of common infec-
tions including hospital admissions. All resource use will
be monitored prospectively. Since this is a 'complex inter-
vention', no attempt will be made to examine the cost
effectiveness of each specific component. Prospective
monitoring of health service resource use, however, will
identify the cost of each element of the intervention. The
different elements will also be examined in the qualitative
study. Education represents a one-off cost which may pro-
duce a stream of benefits over time. Accordingly, the costs
of education can be dealt with similarly to capital equip-
ment with costs expressed on an Equivalent Annual Cost
(EAC) basis[54]. Length of consultation will be estimated
using facilities in existing practice computer systems in a
sample of practices.
The study has been approved by the Multi-centre Research
Ethics Committee (MREC 06/MRE09/31) and all Local
Health Boards (LHBs) in Wales.
Analysis
Main analysis
The main analysis will be intention to treat and will com-
pare the two groups for annual total antibiotics dispensed
per 1000 practice patients within practices in the year fol-
lowing the intervention, using analysis of covariance with
the average of the previous three years' prescribing as a
covariate. Secondary outcomes of average hospital admis-Page 6 of 10
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ance rates will be similarly compared between the two
groups for the whole year. A comparison will be made
between groups for complications managed in primary
care, re-consultations and further consultations for a sim-
ilar illness, using summary data extracted from practice
computer systems, for a subset of practices. Exploratory
analyses will use analysis of covariance to adjust for prac-
tice factors that might plausibly influence outcomes.
Weighted average Townsend scores for each practice will
be used to examine socio-economic influences on pre-
scribing. The degree of uptake of the intervention will be
used in further exploratory models to explore impact on
outcomes. Antibiotics dispensed for intervention and
control practices will be compared to Welsh practices not
participating in the study (those not consented and those
not approached) to assess non-specific effects of taking
part in a trial as well as the external validity of the trial.
Qualitative analysis
We will employ standard thematic analysis techniques,
where transcripts will be closely examined to identify themes
and categories[55]. Codes will be applied to these broad
themes which will then be broken down further into sub-
codes. Agreement on concepts and coding will be sought
between members of the research team in order to ensure
reliability. A proportion of the data (10%) will be coded by
two different team members to check on reliability of the
coding scheme. The interviewing will be iterative, where new
themes emerge we will incorporate them into the interviews.
Thematic analysis will be supported by the use of computer-
assisted qualitative analysis software (NVIVO8).
Cost effectiveness analysis
All resources will be valued using conventional meth-
ods[54]. Totals, means and confidence intervals for each
training component will be identified, and analyzed using
SPSS. Where costs are skewed, bootstrapped confidence
intervals will be used.
The net cost of the intervention (likely to be positive) will
be assessed against the primary outcome (reduction in
dispensed oral antibiotics) to provide an incremental cost
effectiveness ratio (ICER). Although there is a literature on
the effectiveness of measures to improve antibiotic use,
we could identify no comprehensive cost effectiveness
analyses against which the above ICER can be compared.
Accordingly the present study will not be able to provide
evidence to show whether STAR is more or less cost effec-
tive than other measures with the same objective. It will,
however, provide an evidence base for comparison in
future studies.
Discussion
This trial will be the first to evaluate the effectiveness of a
theory-based intervention involving a blended learning
program which focuses on both clinicians' reflections on
their prescribing habits and practice level data on prescrib-
ing and antimicrobial resistance, as well as an introduction
to novel consulting strategies for use during consultations
for common infections. This approach has the potential to
improve communication between clinicians and patients,
as well as reducing unnecessary antibiotic prescribing. One
recent study which focused on improving communication
achieved an impressive 40% relative reduction in antibiotic
prescribing at 12 months[56].
Strengths
This study will be implemented in Wales and will include
general practice surgeries from areas of high social depri-
vation as well as more affluent areas. We will use routine
data as the main outcome which will enable us to com-
pare practices taking part in the study with those outside
the study. We will also be able to look at dispensing data
both before and after the study to examine changes in
behaviour.
Given that in the UK in recent years there has been a con-
siderable reduction in inappropriate antibiotic prescrib-
ing, a reduction of 10% in antibiotic prescribing rates may
seem optimistic. However, taking into account the find-
ings of Welschen[16,33] and Altiner[56] and the fact that
the UK has higher rates of antibiotic prescribing than both
the Netherlands and Germany, and that the intervention
we propose uses an innovative mix of approaches to
behaviour change, we feel that this is nevertheless feasi-
ble.
The main outcome will not simply be antibiotic prescrib-
ing in a single consultation as in individually randomized
trials[57], but rather, antibiotic prescribing for a whole
year. This will allow for assessment of maintenance of
skills and more powerful analyses that better assess the
pragmatic effect of the intervention over time.
The cluster design will limit the chances of contamination.
Once individual practitioners are trained in new consulting
skills and are given new information about the indication
and choice of antibiotic, they could not effectively revert
back to their previous 'usual care' according to individual
patient randomization. All participating clinicians in the
same practice will be randomized to the same intervention
condition to prevent contamination within practices.
Protecting against bias
Practices who volunteer for the study are likely to be moti-
vated to have access to the intervention, so those who are
allocated to the control group may be disappointed. In
order to avoid differential dropout between the experi-
mental and control groups, we will offer those practices in
the control group the opportunity to complete the train-
ing program after the one year follow-up period.Page 7 of 10
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the skills that they have learned in practice, since mainte-
nance of these skills is challenging. Whilst the clinicians
will learn the theory behind the communication skills and
will learn to use the key strategies during consultations
and appreciate the reasons for doing things this way, they
might still not incorporate these into their routine prac-
tice. However, the intervention focuses on why change is
important while at the same time enhancing clinicians'
skills. The strategies taught will fit within the timescale of
a routine consultation and this we hope will increase
uptake. In addition, we will have a 'booster', which will
consist of both on and offline elements to encourage
maintenance of skills.
Evaluations
The study will incorporate both an economic evaluation
and a process evaluation. The process evaluation will
allow us to explore the impact of different aspects of the
intervention. If the trial does not show an effect it will
allow us to explore possible reasons for this. In addition
to estimating the overall cost of the intervention, the eco-
nomic evaluation will identify its effect on consultation
length as this is likely to be a factor of concern to clinicians
which could affect its adoption. One challenge we face is
measuring the impact of using the communication skills
on consultation length. We plan to use the practice com-
puter systems to provide an estimate of this, where possi-
ble.
The STAR Program grew out of seminal qualitative studies
and intervention development research on clinician
behaviour change. This study will therefore not simply
make an incremental contribution. It will evaluate a
unique, yet applicable, approach that has the potential to
radically change research direction, clinical practice and
policy. Since enhanced communication skills are the core
of the intervention, beneficial effects on clinical practice
are likely, not only in the management of common infec-
tions, but also in other clinical areas. The intervention is
easily generalisable and could be rolled out using current
technology and prescribing advisors to deliver the semi-
nars. The intervention design using novel blended learn-
ing approaches will be applicable to continuing
professional development in other clinical domains.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
SS led the writing of this manuscript and developed the
blended learning program, together with Stephen Rolln-
ick. She also contributed to the design of the study. CB is
the Principal Investigator, conceived the study and led the
study design and funding application. KH is a trial statis-
tician and contributed to the study design, and analysis
plan. FD is a trial statistician and contributed to study
design, power calculation and analysis plan. DC is a
health economist and contributed to study design and the
health economics component. ME is a clinical epidemiol-
ogist, he contributed to design of the study. SR is a clinical
psychologist who contributed to study design and the
development of the intervention. LM contributed to the
design of the study. MJB and MH are the trial managers
and contributed to the manuscript. JE is the data manager
who contributed to the manuscript. All authors contrib-
uted to, read and approved the final version of the manu-
script.
Acknowledgements
The authors would like to thank the other members of the STAR study 
team for their contribution to the design and development of this study:
Mr Jamie Hayes
Dr Robin Howe
Mrs Jackie Swain
Mr Mubasiru Lamidi
This study is funded by the United Kingdom Medical Research Council 
(G0500956). The International Standard Randomized Controlled Trial 
Number is 63355948. The South East Wales Trials Unit is funded by the 
Welsh Office of Research and Development for Health and Social Care.
References
1. Department of Health: UK Antimicrobial Resistance Strategy
and Action Plan.  London: Department of Health; 2000. 
2. WHO Strategy for containment of antimicrobial resistance.
WHO 2001.
3. Goossens H, Ferech M, Stichele R Vander, Elseviers M, ESAC Project
Group: Outpatient antibiotic use in Europe and association
with resistance: a cross-national database study.  Lancet 2005,
365(9459):579-587.
4. Norrby S, Nord C, Finch R: Lack of development of new antimi-
crobial drugs: a potential serious threat to public health.  Lan-
cet Infect Dis 2005, 5(2):115-119.
5. Ball P, Baquero F, Cars O, File T, Garau J, Klugman K, Low DE, Rubin-
stein E, Wise R: Antibiotic therapy of community respiratory
tract infections: strategies for optimal outcomes and mini-
mized resistance emergence.  J Antimicrob Chemother 2002,
49(1):31-40.
6. Butler CC, Rollnick S, Kinnersley P, Jones A, Stott NCH: Reducing
antibiotics for respiratory tract symptoms in primary care;
consolidating 'why' and considering 'how'.  Br J Gen Pract 1998,
48:1865-1870.
7. Little , Williamson I: Sore throat management in general prac-
tice.  Fam Pract 1995, 13(3):317-321.
8. Butler CC, Hillier S, Roberts Z, Dunstan F, Howard A, Palmer S:
Antibiotic-resistant infections in primary care are sympto-
matic for longer and increase workload: outcomes for
patients with E. coli UTIs.  Br J Gen Pract 2006, 56(530):686-692.
9. Alam F, Cohen D, Butler C, Dunstan F, Roberts Z, Hillier S, Palmer S:
Additional costs of antibiotics and re-consultations for anti-
biotic resistant E.coli urinary tract infections managed in
general practice.  Int J Antimicrob Agents 2008 in press.
10. Seppala H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager
K, Huovinen P: The effect of changes in the consumption of
macrolide antibiotics on erythromycin resistance in group A
streptococci in Finland. Finnish Study Group for Antimicro-
bial Resistance.  N Engl J Med 1997, 337(7):441-446.Page 8 of 10
(page number not for citation purposes)
BMC Family Practice 2009, 10:20 http://www.biomedcentral.com/1471-2296/10/2011. Butler CC, Dunstan F, Heginbothom M, Mason B, Roberts Z, Hillier
S, Howe R, Palmer S, Howard A: Containing antibiotic resist-
ance: decreased antibiotic-resistant coliform urinary tract
infections with reduction in antibiotic prescribing by general
practices.  Br J Gen Pract 2007, 57(543):785-792.
12. Guillemot D, Varon E, Bernede C, Weber P, Henriet L, Simon S, Lau-
rent C, Lecoeur H, Carbon C: Reduction of antibiotic use in the
community reduces the rate of colonization with penicillin
G-nonsusceptible Streptococcus pneumoniae.  Clin Infect Dis
2005, 41(7):930-938.
13. Wise R, Hart T, Cars O, Streulens M, Helmuth R, Huovinen P,
Sprenger M: Antimicrobial resistance is a major threat to pub-
lic health.  BMJ 1998, 317:609-610.
14. Wrigley T: Age- and sex-specific antibiotic prescribing pat-
terns in general practice in England and Wales, 1994–1998.
Health Stat Q 2002, 14:14-20.
15. Cars O, Molstad S, Melander A: Variation in antibiotic use in the
European Union.  Lancet 2001, 357(9271):1851-1853.
16. Welschen I: Prescribing antibiotics for acute respiratory tract
infections in primary care: improving doctors' prescribing
and exploring patients' satisfaction.  University of Utrecht, Gen-
eral Practice; 2004. 
17. Coenen S, Van Royen P, Michiels B, Denekens J: Optimizing antibi-
otic prescribing for acute cough in general practice: a clus-
ter-randomized controlled trial.  J Antimicrob Chemother 2004,
54(3):661-672.
18. Bandura A: Social Foundations of Thought and Action: A Social Cognitive
Theory New Jersey: Prentice Hall, Eaglewood Cliffs; 1986. 
19. Bandura A: Health promotion from the perspective of social
cognitive theory.  Psychol Health 1998, 13(4):623-649.
20. Ajzen I: Perceived behavioural control, self efficacy, locus of
control and the theory of planned behaviour.  J Appl Psychol
2002, 32:1-20.
21. Hardeman W, Johnston M, Johnston D, Bonetti D, Wareham N, Kin-
month A: Application of the theory of planned behaviour in
behaviour change interventions: a systematic review.  Psychol
Health 2002, 17(2):123-158.
22. Armitage CJ, Conner M: Efficacy of the Theory of Planned
Behaviour: a meta-analytic review.  Br J Soc Psychol 2001, 40(Pt
4):471-499.
23. Martens J, Winkens R, Weijden T van der, de Bruyn D, Severens J:
Does a joint development and dissemination of multidiscipli-
nary guidelines improve prescribing behaviour: a pre/post
study with concurrent control group and a randomised trial.
BMC Health Serv Res 2006, 2(6):145.
24. van Driel M, Coenen S, Dirven K, Lobbestael J, Janssens I, Van Royen
P, Haaijer-Ruskamp F, De Meyere M, De Maeseneer J, Christiaens T:
What is the role of quality circles in strategies to optimise
antibiotic prescribing? A pragmatic cluster-randomised con-
trolled trial in primary care.  Qual Saf Health Care 2007,
16(3):197-202.
25. Oxman AD, Thomson MA, Davis DA, Haynes RB: No magic bul-
lets: a systematic review of 102 trials of interventions to
improve professional practice.  CMAJ 1995, 153(10):1423-1431.
26. Davis DA, Thompson MA, Oxman AD, Haynes RB: Changing phy-
sician performance. A systematic review of the effect of con-
tinuing medical education strategies.  JAMA 1995, 274:700-705.
27. Thomson O'Brien MA, Oxman AD, Davis DA, Haynes RB, Freeman-
tle N, Harvey EL: Educational outreach visits: effects on profes-
sional practice and health care outcomes.  Cochrane Database
Syst Rev 2000:CD000409.
28. Grimshaw JM, Shirran L, Thomas R, Mowatt G, Fraser C, Bero L, Grilli
R, Harvey E, Oxman A, O'Brien MA: Changing provider behav-
iour: an overview of systematic reviews of interventions.  Med
Care 2001, 39(8 Suppl 2):II2-45.
29. Smith WR: Evidence for the effectiveness of techniques to
change physician behaviour.  Chest 2000, 118(2 Suppl):8S-17S.
30. Finch RG, Metlay JP, Davey PG, Baker LJ: Educational interven-
tions to improve antibiotic use in the community: report
from the International Forum on Antibiotic Resistance
(IFAR) colloquium, 2002.  Lancet Infect Dis 2004, 4(1):44-53.
31. Foy R, MacLennan G, Grimshaw J, Penney G, Campbell M, Grol R:
Attributes of clinical recommendations that influence
change in practice following audit and feedback.  J Clin Epide-
miol 2002, 55(7):717-722.
32. Arroll B, Kenealy T, Kerse N: Do delayed prescriptions reduce
antibiotic use in respiratory tract infections? A systematic
review.  Br J Gen Pract 2003, 53(496):871-877.
33. Welschen I, Kuyvenhoven M, Hoes A, TJ. V: Effectiveness of a mul-
tiple intervention to reduce antibiotic prescribing for respi-
ratory tract symptoms in primary care: randomised
controlled trial.  BMJ 2004, 329(431):.
34. Rollnick S, Seale C, Kinnersley P, Rees M, Butler C, Hood K: Devel-
oping a new line of patter: can doctors change their consul-
tations for sore throat?  Med Educ 2002, 36(7):678-681.
35. Butler CC, Pill RM, Stott NCH: A qualitative study of patients'
perceptions of doctors' advice to quit smoking; implications
for opportunistic health promotion.  BMJ 1998, 316:1878-1881.
36. Grol R, Baker R, Moss F: Quality improvement research: under-
standing the science of change in health care.  Qual Saf Health
Care 2002, 11(2):110-111.
37. Wood F, Simpson S, Butler CC: Socially responsible antibiotic
choices in primary care: a qualitative study of GPs' decisions
to prescribe broad-spectrum and fluroquinolone antibiotics.
Fam Pract 2007, 24(5):427-434.
38. Butler CC, Rollnick S, Maggs-Rapport F, Pill RM, Stott NCH: Under-
standing the culture of prescribing: A qualitative study of
general practitioners' and patients' perceptions of antibiot-
ics for sore throats.  BMJ 1998, 317:637-642.
39. Simpson SA, Wood F, Butler CC: General practitioners' percep-
tions of antimicrobial resistance: a qualitative study.  J Antimi-
crob Chemother 2007, 59(2):292-296.
40. Magee JT, Pritchard EL, Fitzgerald KA, Dunstan FDJ, Howard AJ:
Antibiotic prescribing and antibiotic resistance in commu-
nity practice: retrospective study, 1996–8.  BMJ 1999,
319:1239-1240.
41. Davey P, Pagliari C, Hayes A: The patient's role in the spread and
control of bacterial resistance to antibiotics.  Clin Microbiol
Infect 2002, 8(Suppl 2):43-68.
42. Kumar S, Little P, Britten N: Why do general practitioners pre-
scribe antibiotics for sore throat? Grounded theory inter-
view study.  BMJ 2003, 326(7381):138.
43. Butler CC, Rollnick S, Kinnersley P, Tapper-Jones L, Houston H:
Communicating about expected course and re-consultation
for respiratory tract infections in children: an exploratory
study.  Br J Gen Pract 2004, 54(504):536-538.
44. Rollnick S, Seale C, Rees M, Butler C, Kinnersley P, Anderson L:
Inside the routine general practice consultation: an observa-
tional study of consultations for sore throats.  Fam Pract 2001,
18(5):506-510.
45. Cockburn J, Pit S: Prescribing behaviour in clinical practice:
Patients' expectations and doctors' perceptions of patients'
expectations – a questionnaire study.  BMJ 1997, 315:520-523.
46. Britten N, Ukoumunne O: The influence of patients' hopes of
receiving a prescription on doctors' perceptions and the
decision to prescribe: a questionnaire survey.  BMJ 1997,
315:1506-1510.
47. Barry CA, Bradley CP, Britten N, Stevenson FA, Barber N: Patients'
unvoiced agendas in general practice consultations: qualita-
tive study.  BMJ 2000, 320:1246-1250.
48. Butler CC, Prout H, Kinnersley P, Rollnick S, Edwards A, Elwyn G:
Shared decision making and antibiotics in primary care.  J
Antimicrob Chemother 2001, 48:435-440.
49. Rollnick S, Mason P, Butler CC: Health behaviour change: A guide for
practitioners Edinburgh: Churchill Livingstone; 1999. 
50. Rollnick S, Kinnersley P, Butler C: Context-bound communica-
tion skills training: development of a new method.  Med Educ
2002, 36(4):377-383.
51. Raab G, Butcher I: Balance in Cluster Randomised Trials.  Stat
Med 2001, 20:351-365.
52. Carter B, Hood K: Balance algorithm for cluster randomized
trials.  BMC Med Res Methodol 2008, 8(1):65.
53. Morse J: Determining sample size.  Qual Health Res 2000,
10(1):3-5.
54. Drummond MF, O'Brien B, Stoddard G, Torrnace G: Methods for the
economic evaluation of health care programmes 2nd edition. Oxford:
Oxford University Press; 1996. 
55. Green J, Thorogood N: Qualitative methods for Health Research Lon-
don: Sage; 2004. 
56. Altiner A, Brockmann S, Sielk M, Wilm S, Wegscheider K, Abholz H:
Reducing antibiotic prescriptions for acute cough by moti-Page 9 of 10
(page number not for citation purposes)
BMC Family Practice 2009, 10:20 http://www.biomedcentral.com/1471-2296/10/20Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
vating GPs to change their attitudes to communication and
empowering patients: a cluster-randomized intervention
study.  J Antimicrob Chemother 2007, 60(3):638-644.
57. Cals J, Hopstaken R, Butler C, Hood K, Severens J, Dinant G:
Improving management of patients with acute cough by C-
reactive protein point of care testing and communication
training (IMPAC3T): study protocol of a cluster randomised
controlled trial.  BMC Fam Pract 2007, 29(8):15.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2296/10/20/pre
pubPage 10 of 10
(page number not for citation purposes)
